Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on nephropathic cystinosis.

J A Schneider1, B Katz, R B Melles

  • 1University of California at San Diego, La Jolla 92093-0609.

Pediatric Nephrology (Berlin, Germany)
|November 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbial Indicators of Dental Health, Dysbiosis, and Early Childhood Caries.

Journal of dental research·2023
Same author

Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Improving Caries Risk Prediction Modeling: A Call for Action.

Journal of dental research·2020
Same author

Maturation of the Oral Microbiome in Caries-Free Toddlers: A Longitudinal Study.

Journal of dental research·2019
Same author

Biomarkers of inflammation - LBP and TLR- predict progression of knee osteoarthritis in the DOXY clinical trial.

Osteoarthritis and cartilage·2018
Same author

Fluoride Use in Health Care Settings: Association with Children's Caries Risk.

Advances in dental research·2018

Cystinosis is a genetic disorder where cystine accumulates in lysosomes due to a defective transporter. Cysteamine treatment helps remove cystine, potentially preventing organ damage and the need for kidney transplantation in patients.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Cystinosis is a lysosomal storage disease characterized by the accumulation of cystine within lysosomes.
  • This accumulation results from a defective lysosomal cystine transporter, a defect shared across all cystinosis types.
  • Genetic analysis of fused cells from different cystinosis forms suggests allelic defects.

Purpose of the Study:

  • To investigate the underlying genetic defect in cystinosis.
  • To evaluate the efficacy of cysteamine as a therapeutic agent for cystinosis.
  • To understand the long-term implications of cystinosis and its treatment.

Main Methods:

  • Cell fusion experiments were conducted using cells from patients with nephropathic and benign cystinosis.
  • The mechanism of cystine transport out of lysosomes was examined.

Related Experiment Videos

  • The therapeutic effect of cysteamine and phosphocysteamine was assessed in patients.

    • Main Results:

    • Cell fusion did not correct the defective cystine transport, indicating allelic genetic defects.
    • Cysteamine forms a mixed disulfide with half-cystine, which is then transported out of the lysosome via a normal cationic amino acid transporter.
    • Cysteamine and phosphocysteamine show significant benefits for cystinosis patients, particularly when initiated early.

    Conclusions:

    • The genetic defects in cystinosis are allelic, affecting the lysosomal cystine transporter.
    • Cysteamine treatment offers a promising therapeutic strategy by facilitating cystine removal from lysosomes.
    • Early intervention with cysteamine may prevent organ damage and reduce the need for renal transplantation, though long-term effects on other organs require further study.